Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% Growth Achieves 49% Growth in Adjusted EBITDA to Record $187.1 Million Issues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint NEW YORK, February 27, 2024 /GlobeNewswire/ - Progyny, Inc. (Nasdaq: PGNY) ("Progyny" or the "Company"), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the three- and twelve-month periods ended December 31, 2023 ...

Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________________________________ Delaware 27-2220139 (State or other jurisdiction of incorporation or organization) FORM 10-Q ____________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ...

Progyny, Inc. (NASDAQ:PGNY) Q3 2023 Earnings Conference Call November 7, 2023 9:00 PM ET Company Participants James Hart - IR Pete Anevski - CEO Michael Sturmer - President Mark Livingston - CFO Conference Call Participants Anne Samuel - JPMorgan Scott Schoenhaus - KeyBanc Jailendra Singh - Truist Securities Sarah James - Cantor Richard Close - Canaccord Allen Lutz - Bank of America David Larsen - BTIG Operator Good day, everyone, and welcome to the Progyny, Inc. Third Quarter 2023 Earnings Call. [Operator ...

Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________________________________ FORM 10-Q ____________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commissi ...

Progyny, Inc. (NASDAQ:PGNY) Q2 2023 Earnings Conference Call August 3, 2023 4:45 PM ET Company Participants James Hart - IR Pete Anevski - CEO Michael Sturmer - President Mark Livingston - CFO Conference Call Participants Michael Cherny - Bank of America Scott Schoenhaus - KeyBanc Jailendra Singh - Truist David Larsen - BTIG Operator Good day, everyone, and welcome to the Progyny, Inc. Second Quarter 2023 Earnings Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, James ...

WASHINGTON, D.C. 20549 ____________________________________________ FORM 10-Q ____________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number: 001-39100 ____________________________________________ Progyny, Inc. (Exact name of registrant as specified in its charter) ________________________ ...

Progyny, Inc. (NASDAQ:PGNY) Q1 2023 Earnings Conference Call May 8, 2023 4:45 PM ET Company Participants James Hart - Investor Relations Pete Anevski - Chief Executive Officer Michael Sturmer - President Mark Livingston - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Scott Schoenhaus - KeyBanc Sarah James - Cantor Fitzgerald Eduardo Ron - Truist Securities Anna Kruszenski - SVB Securities Michael Weisberg - Crestwood Capital Operator Good day, ladies and gentlemen and welcome t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number: 001-39100 Progyny, Inc. (Exact name of registrant as specified in its charter) ...

Progyny, Inc. (NASDAQ:PGNY) Q4 2022 Earnings Conference Call February 27, 2023 4:45 PM ET Company Participants James Hart - Vice President of Investor Relations Peter Anevski - Chief Executive Officer Mark Livingston - Chief Financial Officer Michael Sturmer - President Conference Call Participants Michael Cherny - Bank of America Jailendra Singh - Truist Securities Scott Schoenhaus - KeyBanc Stephanie Davis - SVB Securities Operator Good day, ladies and gentlemen and welcome to the Progyny Inc. Fourth Quar ...

Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________________________________ FORM 10-Q ____________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Com ...